JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2006; 47:1379-1381, doi:10.1016/j.jacc.2006.01.034 (Published online 14 March 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jialal, I.
Right arrow Articles by Singh, U.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jialal, I.
Right arrow Articles by Singh, U.

C-Reactive Protein and the Vascular Endothelium

Implications for Plaque Instability*

Ishwarlal Jialal, MD, PhD*, Sridevi Devaraj, PhD and Uma Singh, PhD

Laboratory for Atherosclerosis and Metabolic Research, University of California at Davis Medical Center, Sacramento, California


Figure 1
View larger version (58K):

[in a new window]
  		Figure 1 Effects of C-reactive protein (CRP) on the vascular endothelium. CAMS = cell adhesion molecules; eNOS = endothelial nitric oxide synthase; Fc{gamma} = fragment of antibody with the c-terminal of immunoglobulin chain; IL = interleukin; MAPK = mitogen-activated protein kinase; MCP 1 = monocyte chemotactic protein-1; MMP-1 = matrix metalloproteinase-1; NFKb = nuclear factor kb; PAI-1 = plasminogen activator inhibitor-1; TNF = tumor necrosis factor; tPA = tissue plasminogen activator.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.